TMST

Company Overview

Snapshot

Founded in January 2016, TMST operates with 1–10 employees. The company received a grant from MassChallenge Israel in November 2016.

Business overview

TMST is a Health Tech & Life Sciences company developing a non-invasive acoustic neuromodulation device designed to reduce spasticity. The company's core technology involves Targeted Modulated Sound Therapy delivered via acoustic wearables, including a headset and a bone conduction device. These devices are complemented by a mobile application providing professional support and guidance. TMST targets the healthcare market, serving hospitals, clinics, and individual patients through B2B2C and B2B business models, operating within the Medical Devices sector.

Company Intelligence Q&A

What is TMST's primary focus?

TMST is focused on developing a non-invasive acoustic neuromodulation device to decrease spasticity using Targeted Modulated Sound Therapy.

When was TMST founded?

TMST was founded in January 2016.

What type of products does TMST plan to develop?

TMST plans to develop and market two acoustic wearables: a headset and a bone conduction device, both pre-installed with the TMST sound module. An accompanying app will provide support and guidance.

What is TMST's current employee count?

TMST currently has 1–10 employees.